StonvexLoading…
StonvexStonvexStonvexCore line items from CCL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-02-28 | Annual 2025 2025-11-30 | Q3 2025 2025-08-31 | Q2 2025 2025-05-31 |
|---|---|---|---|---|
Revenue | $6.17B | $26.62B | $20.29B | $12.14B |
Operating Income | $607.00M | $4.48B | $3.75B | $1.48B |
Net Income | $258.00M | $2.76B | $2.34B | $486.00M |
EPS (Diluted) | $0.19 | $2.02 | $1.71 | $0.37 |
Total Assets | $51.57B | $51.69B | $50.83B | $51.16B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.42B | $1.93B | $1.76B | $2.15B |
Free Cash Flow OCF − CapEx | $697.00M | $2.61B | $2.60B | $1.86B |
Shares Outstanding | 1.39B | 1.40B | 1.40B | 1.32B |